Eledon 製藥公司
DE ˙ DB ˙ US28617K1016
€2.92 ↓ -0.04 (-1.35%)
2026-06-04
分享價格
SecurityDE:2TK / Eledon Pharmaceuticals, Inc.
InstitutionRenaissance Technologies Llc
ManagerJames Simons
Latest Disclosed Ownership24,600 shares
Latest Disclosed Value $ 75,768
Renaissance Technologies Llc reports 86.10% decrease in ownership of 2TK / Eledon Pharmaceuticals, Inc.

On May 14, 2026 - Renaissance Technologies Llc filed a 13F-HR form disclosing ownership of 24,600 shares of Eledon Pharmaceuticals, Inc. (DE:2TK) valued at $56,580 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 176,990 shares of Eledon Pharmaceuticals, Inc.. This represents a change in shares of -86.10% during the quarter. The current value of the position is $71,832 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 24,600 -152,390 -86.10 76 -71.91 0.0001
2026-02-12 2025-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 176,990 -172,210 -49.32 267 -70.46 0.0004
2025-11-13 2025-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 349,200 158,527 83.14 904 75.19 0.0012
2025-08-13 2025-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 190,673 67,900 55.31 517 24.04 0.0007
2025-05-14 2025-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 122,773 -24,400 -16.58 416 -31.35 0.0006
2025-02-13 2024-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 147,173 11,300 8.32 606 79.29 0.0009
2024-11-13 2024-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 135,873 -900 -0.66 338 -6.37 0.0005
2024-08-09 2024-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 136,773 49,704 57.09 361 0.0006
2024-05-13 2024-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 87,069 17,896 25.87 0 0.0003
2024-02-13 2023-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 69,173 7,200 11.62 0 0.0002
2023-11-14 2023-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 61,973 1,600 2.65 0 0.0001
2023-08-11 2023-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 60,373 28,200 87.65 0 0.0001
2023-05-12 2023-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 32,173 2,500 8.43 0 0.0001
2023-02-13 2022-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 29,673 -2,200 -6.90 0 -100.00 0.0001
2022-11-14 2022-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 31,873 -300 -0.93 88 11.39 0.0001
2022-08-12 2022-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 32,173 13,700 74.16 79 8.22 0.0001
2022-05-13 2022-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 18,473 4,800 35.11 73 21.67 0.0001
2022-02-11 2021-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 13,673 -25,990 -65.53 60 -75.51 0.0001
2021-11-12 2021-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 39,663 18,556 87.91 245 46.71 0.0003
2021-08-13 2021-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 21,107 -5,944 -21.97 167 -42.21 0.0002
2021-05-13 2021-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 27,051 -16,200 -37.46 289 -56.61 0.0004
2021-02-10 2020-12-31 13F NOVUS THERAPEUTICS COM 67011N204 43,251 -714,898 -94.30 666 -7.50 0.0007
2020-11-13 2020-09-30 13F NOVUS THERAPEUTICS COM 67011N105 758,149 122,869 19.34 720 147.42 0.0007
2020-08-13 2020-06-30 13F NOVUS THERAPEUTICS COM 67011N105 635,280 177,956 38.91 291 63.48 0.0003
2020-05-14 2020-03-31 13F NOVUS THERAPEUTICS COM 67011N105 457,324 1,588 0.35 178 -32.58 0.0002
2020-02-13 2019-12-31 13F NOVUS THERAPEUTICS COM 67011N105 455,736 73,500 19.23 264 11.39 0.0002
2019-11-13 2019-09-30 13F NOVUS THERAPEUTICS COM 67011N105 382,236 -27,220 -6.65 237 -42.75 0.0002
2019-08-12 2019-06-30 13F NOVUS THERAPEUTICS COM 67011N105 409,456 207,550 102.80 414 -49.01 0.0004
2019-05-14 2019-03-31 13F NOVUS THERAPEUTICS COM 67011N105 201,906 -31,896 -13.64 812 117.11 0.0007
2019-02-12 2018-12-31 13F NOVUS THERAPEUTICS COM 67011N105 233,802 -17,754 -7.06 374 -68.17 0.0004
2018-11-13 2018-09-30 13F NOVUS THERAPEUTICS COM 67011N105 251,556 55,968 28.62 1,175 -14.17 0.0012
2018-08-13 2018-06-30 13F/A-1 NOVUS THERAPEUTICS COM 67011N105 195,588 85,712 78.01 1,369 147.11 0.0015
2018-08-13 2018-06-30 13F NOVUS THERAPEUTICS COM 67011N105 109,876 554
2018-05-14 2018-03-31 13F NOVUS THERAPEUTICS COM 67011N105 109,876 16,600 17.80 554 46.17 0.0006
2018-02-13 2017-12-31 13F NOVUS THERAPEUTICS COM 67011N105 93,276 9,400 11.21 379 -13.27 0.0004
2017-11-13 2017-09-30 13F NOVUS THERAPEUTICS COM 67011N105 83,876 21,100 33.61 437 19.07 0.0005
2017-08-11 2017-06-30 13F NOVUS THERAPEUTICS COM 67011N105 62,776 -348,324 -84.73 367 7.00 0.0005
2017-05-12 2017-03-31 13F TOKAI PHARMACEUTICALS COM 88907J107 411,100 51,900 14.45 343 -2.28 0.0005
2017-02-13 2016-12-31 13F TOKAI PHARMACEUTICALS COM 88907J107 359,200 143,200 66.30 351 6.36 0.0006
2016-11-14 2016-09-30 13F TOKAI PHARMACEUTICALS COM 88907J107 216,000 202,200 1,465.22 330 334.21 0.0006
2016-08-12 2016-06-30 13F TOKAI PHARMACEUTICALS COM 88907J107 13,800 -3,400 -19.77 76 -20.83 0.0001
2016-05-13 2016-03-31 13F TOKAI PHARMACEUTICALS COM 88907J107 17,200 -25,000 -59.24 96 -73.91 0.0002
2016-02-11 2015-12-31 13F TOKAI PHARMACEUTICALS COM 88907J107 42,200 42,200 368 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.